Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials.

Adv Sci (Weinh) · 2026 · PMC12806205 · PMID 41159493

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although these differences were not statistically significant, they showed a trend.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Notably, the differences between LIRA and TPS or TMB in the ORIENT‐11 and NFH cohorts did not reach statistical significance, which may be due to the limited number of patients with TPS and TMB data, potentially leading to insufficient statistical power to detect significant differences.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.